Report ranks Indiana 32nd for child well-being
The national report found that more Indiana children have health insurance and fewer are abusing drugs and alcohol, but the state still dropped in the rankings due to improved results in other states.
Health Care
Articles
Indy-based health data firm snares $1.5M in VC round
Healthiest Employers LLC, which collects and measures corporate health information, plans to use the funds to drive sales of its analytics software.
Cook Pharmica to hire 70 workers to expand drug-making capacity
Cook Pharmica, a subsidiary of Bloomington-based medical device maker Cook Group, currently employs 575 workers who manufacture and package drugs for use in clinical trials or for sale on the market.
St. Vincent to dangle health insurance deal to employers
The hospital system and a partner company have started meeting with health insurance brokers to pitch a program to save employers money by keeping workers and their families healthier.
UPDATE: Pence, other governors order Planned Parenthood probes
Gov. Mike Pence has directed the Indiana Department of Health to investigate whether organs from aborted fetuses are being sold.
Lilly partner Immunocore raises record $320 million
Immunocore Ltd., which this week achieved the biggest private fundraising by a European biotechnology firm in 10 years, plans to accelerate development of its cancer therapy using the money and seek expedited approval.
FAST 25: Mainstreet
When you have a health care business for which “there’s a tremendous need and virtually no product”—which Mainstreet founder and CEO Zeke Turner said is what his company has—growth potential would seem unlimited.
Health care industry: Healthy Indiana Plan working smoothly
State enrollment in HIP 2.0 has climbed to nearly 290,000 participants, with about 60 percent of those people under age 40, according to state figures presented Thursday.
Lilly, partner sue Lupin over generic testosterone
Indianapolis-based Eli Lilly and Co. and Acrux DDS Pty Ltd. have filed a lawsuit against Lupin Pharmaceuticals Inc. for alleged infringement of patents that cover the testosterone treatment Axiron.
Clot risk in Lilly lung-cancer drug raises FDA concerns
The drug, known as necitumumab, improved patients’ overall chances of survival, yet people taking the medicine also experienced more risk, Food and Drug Administration staff said in a report Tuesday.
Aetna-Humana deal could push Cigna to take Anthem offer
With Aetna Inc. and Humana Inc. agreeing to a $37 billion merger, pressure is mounting on the other major health insurers, including Cigna Corp. and Anthem Inc., to make their own deals.
Aetna agrees to buy Humana in $37B deal
Aetna Inc. agreed to buy Humana Inc., the second-largest provider of private Medicare insurance, for $37 billion in cash and stock to broaden its health-care coverage.
Brownsburg entrepreneur is a cryogenic-tooth-banking pioneer
Michael A. Byers’ Tooth Bank is one of a tiny group of U.S. companies catering to the latest iteration of stem cell therapy: harvesting stem cells from the pulp inside baby teeth and extracted wisdom teeth, then culturing, freezing and storing them at a cryostorage facility for later use.
Cook deluged by product lawsuits
Patients from around the country have filed 100 lawsuits against Bloomington-based Cook, alleging that some of its blood-clot filters have broken apart, moved or poked through the blood vessel where they are implanted.
Community Health to pay $20M to settle false claims charges
The Indianapolis-based hospital system has agreed to pay $20.3 million to settle claims that it overbilled the Medicare and Medicaid programs.
Familiar culprit holds up Anthem-Cigna merger
Anthem Inc.’s proposed $47 billion buyout of Cigna Corp. is the latest example of corporate deals that get hung up over executive egos and turf battles. For example, Anthem CEO Joe Swedish wants to lead the merged firm, to the chagrin of Cigna’s CEO.
Firm looks to bulk up on fat-reduction results
Wellness company On Target Health LLC, which one year ago launched a program to help overweight workers lose fat but not muscle, is seeing strong results from its first two clients.
British court ruling backs patent protecting Lilly’s Alimta
Eli Lilly and Co. received some European legal backing for its top product, the lung cancer treatment Alimta, on Thursday when a British court upheld a patent protecting a vitamin regimen administered with the drug.
Lilly facing first trials over Cymbalta withdrawal symptoms
Eli Lilly and Co. has been ordered to face claims it misled consumers about “brain zaps” and other withdrawal side effects tied to its antidepressant Cymbalta in the first cases slated to be heard by juries.
Zimmer, Biomet complete $13.35 billion merger
The Indiana-based company has taken the name Zimmer Biomet Holdings Inc. and will trade under the ticker symbol to "ZBH" on Monday. Zimmer Holdings Inc. agreed to buy privately-held Biomet in April 2014.